Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  tiazofurin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-23 of 23 for your search:
Start Over
Phase I/II Study of Chemotherapy with Tiazofurin in Adult Patients with ANLL, Nonlymphoid Blast Crisis of CML, Secondary Leukemia, and Advanced Stages of the Myelodysplastic Syndromes
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: IUMC-851130, NCI-T85-0250R, T85-0250
Phase I/II Pilot Study of Tiazofurin in Adults with AML, ALL, Nonlymphoid Blast Crisis of CML, Secondary AML, and Advanced Stage Myelodysplastic Syndrome
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: IUMC-890117, NCI-T88-0075O, T88-0075
Phase I/II Study of Tiazofurin in Patients with CML in Blast Crisis (Summary Last Modified 06/89)
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-88108, NCI-T88-0198C, T88-0198
Phase II Study of Tiazofurin in Patients with CML in Blast Crisis (Summary Last Modified 04/98)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI
Protocol IDs: BUMC-3333, NCI-T90-0213O, T90-0213
Phase II Chemotherapy with Tiazofurin in Patients with Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-8420, NCI-T84-0369D, T84-0369
Phase II Chemotherapy with Tiazofurin for Recurrent Squamous Cell Carcinoma of the Head and Neck
Phase: Phase II
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: MDA-DM-8516, NCI-T84-0421C, T84-0421
Phase II Chemotherapy with Tiazofurin in Patients with Unresectable Recurrent or Metastatic Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAOP-8185
Phase II Chemotherapy with Tiazofurin in Patients with Advanced non-Small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND11, NCI-T85-0019W, T85-0019, IND11
Phase II Chemotherapy with Tiazofurin in Patients with Advanced Colorectal Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND9, NCI-T85-0018W, T85-0018, IND9
Phase II Chemotherapy with Tiazofurin in Patients with Refractory Metastatic Breast Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CAN-NCIC-IND10, NCI-T85-0101W, T85-0101, IND10
Phase II Study of Tiazofurin in Patients with Malignant Astrocytoma (Summary Last Modified 03/91)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-NCIC-IND54, NCI-T90-0007O, T90-0007, IND54
Phase I Clinical Pharmacologic Study of Tiazofurin
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: MSKCC-8367R, NCI-T83-1117W, T83-1117
Phase I and Pharmacokinetic Study of Tiazofurin (NSC-286193) in Adults
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor:
Protocol IDs: NCI-83-C-31, NCI-MB-CPB-174, NCI-W83-0447, W83-0447
Phase I Testing of Riboxamide (NSC-286193)
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: NCI-W82-1515, CTEPIS-0080, W82-1515
Phase I Study of Tiazofurin (NSC-286193)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 14 and over
Sponsor:
Protocol IDs: NCI-W83-0251
Phase I Study of Tiazofurin (NSC-286193) in Pediatric Patients
Phase: Phase I
Type: Treatment
Status: Completed
Age: under 18
Sponsor:
Protocol IDs: NCI-83-C-38A, CCG-094, NCI-W83-0323, W83-0323
Phase I Study of Riboxamide (Tiazofurin)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: NCI-W83-0339, CAN-NCIC-OTT-8207
Phase I Evaluation of Tiazofurin
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: MAYO-830102, NCI-T83-1072W
Phase I Evaluation of Tiazofurin Administered as a Continuous Infusion for Five Days
Phase: Phase I
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: WCCC-CO-8295, NCI-W83-0581
Phase I Chemotherapy with Tiazofurin on a Weekly Schedule in Adult Patients with Refractory Solid Tumors
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UTHSC-83405193, NCI-T84-0351W, T84-0351
Phase I Study of Tiazofurin/BCNU in Patients with Solid Tumors (Summary Last Modified 09/89)
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: CWRCC-ICC-1989, NCI-T88-0235D, T88-0235
Phase I Trial of Tiazofurin and Thioguanine in Children with Acute Refractory Leukemia (Summary Last Modified 04/2000)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-9370
Start Over